Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Change in Receivables: 2024-2025

Historic Change in Receivables for Gossamer Bio (GOSS) over the last 2 years, with Sep 2025 value amounting to $1.7 million.

  • Gossamer Bio's Change in Receivables fell 43.76% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year change of. This contributed to the annual value of $5.3 million for FY2024, which is N/A change from last year.
  • Latest data reveals that Gossamer Bio reported Change in Receivables of $1.7 million as of Q3 2025, which was up 67.07% from $996,000 recorded in Q2 2025.
  • In the past 5 years, Gossamer Bio's Change in Receivables ranged from a high of $3.6 million in Q2 2024 and a low of -$1.2 million during Q4 2024.
  • Over the past 2 years, Gossamer Bio's median Change in Receivables value was $1.5 million (recorded in 2025), while the average stood at $1.5 million.
  • Data for Gossamer Bio's Change in Receivables shows a maximum YoY tumbled of 72.55% (in 2025) over the last 5 years.
  • Over the past 2 years, Gossamer Bio's Change in Receivables (Quarterly) stood at -$1.2 million in 2024, then plummeted by 43.76% to $1.7 million in 2025.
  • Its last three reported values are $1.7 million in Q3 2025, $996,000 for Q2 2025, and $1.2 million during Q1 2025.